CERSs including CERS2, CERS4, and CERS6 are overexpressed in malignant breast tissues14,15 Human bladder carcinoma patients with loss of CERS2 mRNA expression have poor prognosis, and is associated with tumor progression and invasion16. This evidence concerns the gene CERS2 and neoplasm.